Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Avnet, Inc.’s ( AVT - Analyst Report ) operating unit, Avnet Technology Solutions, has recently declared that its partners in the U.S. and Canada can now access its latest Cloud Evolution Paks (E-Paks). These newly introduced offerings would facilitate Avnet’s clients to easily deploy private cloud-rated facilities through HP CloudSystem or HP Cloud Service Automation.
The company in association with recently acquired Pepperweed Consulting has developed E-Paks. Designed with Pepperweed’s Evolution IP, E-Paks is a wide collection of packaged implementation services.
According to management, Avnet with the help of HP certified professionals is assisting its partners to use private cloud platform within a fixed price and time. E-Paks would not only broaden the company’s product portfolio but also help its partners to improve their entire IT services thus enhancing their business.
Avnet is a global leader in the supply of electronic components and computing products. The company’s broad portfolio of products and services and its continued efforts to ensure maximum consumer satisfaction has helped it to secure a substantial market share in the present scenario.
Avnet faces fierce competition from big players in the semiconductor industry. One of the stalwarts here is Arrow Electronics Inc. ( ARW - Analyst Report ) , which remains an immensely formidable rival, especially in the current times. It has recently expanded its cloud portal by introducing field-programmable gate array (FPGA) power solutions for clients in North America, and the Europe, the Middle East and Africa (EMEA) region. In addition, there are several other big players such as Wesco International Inc. ( WCC - Analyst Report ) and Anixter International Inc. ( AXE - Snapshot Report ) in the industry.
The current Zacks Consensus Estimates for the first quarter of fiscal 2013 and for fiscal 2013 are 84 cents and $4.09, representing year-over-year growth of (6.79%) and 0.76%, respectively.
We currently maintain a ‘Neutral’ recommendation on Avnet. The stock carries a Zacks #4 Rank, translating into a short-term (1-3 months) ‘Sell’ rating.
Read the full reports :
Analyst Report on ARW
Analyst Report on AVT
Analyst Report on WCC
Snapshot Report on AXE